Sarcoma  >>  socazolimab (STI-A1014)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
socazolimab (STI-A1014) / Sorrento
NCT03676985: A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma

Recruiting
1/2
15
RoW
ZKAB001 5mg/kg, PD-L1 monoclonal antibody, ZKAB001 10mg/kg, ZKAB001 15mg/kg
Lee's Pharmaceutical Limited
Osteosarcoma
02/20
06/23

Download Options